Heparin-induced血小板减少。

Kazuo Nakamura
{"title":"Heparin-induced血小板减少。","authors":"Kazuo Nakamura","doi":"10.5772/25401","DOIUrl":null,"url":null,"abstract":"Heparin is an effective anti-coagulant for the prevention of venous thromboembolism and for the treatment of venous thrombosis and pulmonary embolism (Girolami et al., 2003; Hirsh et al., 2004; Shantsila et al., 2009). It is often used for patients with unstable angina and acute myocardial infarction, and for patients who have undergone vascular surgery (Battistelli et al., 2010). The administration of heparin frequently induces a reduction in platelet counts. This phenomenon is called heparin-induced thrombocytopenia (HIT) and be classified as either type I or II. To avoid confusion between the syndromes, “HIT type I” has been changed to “non-immune heparin associated thrombocytopenia”, and ‘‘HIT type II’’ is simply called ‘‘HIT’’.","PeriodicalId":22925,"journal":{"name":"The Western journal of medicine","volume":"414 1","pages":"80-2"},"PeriodicalIF":0.0000,"publicationDate":"2012-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Heparin-induced thrombocytopenia.\",\"authors\":\"Kazuo Nakamura\",\"doi\":\"10.5772/25401\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Heparin is an effective anti-coagulant for the prevention of venous thromboembolism and for the treatment of venous thrombosis and pulmonary embolism (Girolami et al., 2003; Hirsh et al., 2004; Shantsila et al., 2009). It is often used for patients with unstable angina and acute myocardial infarction, and for patients who have undergone vascular surgery (Battistelli et al., 2010). The administration of heparin frequently induces a reduction in platelet counts. This phenomenon is called heparin-induced thrombocytopenia (HIT) and be classified as either type I or II. To avoid confusion between the syndromes, “HIT type I” has been changed to “non-immune heparin associated thrombocytopenia”, and ‘‘HIT type II’’ is simply called ‘‘HIT’’.\",\"PeriodicalId\":22925,\"journal\":{\"name\":\"The Western journal of medicine\",\"volume\":\"414 1\",\"pages\":\"80-2\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-03-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Western journal of medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5772/25401\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Western journal of medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5772/25401","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

肝素是一种有效的抗凝剂,可预防静脉血栓栓塞,治疗静脉血栓和肺栓塞(Girolami等,2003;Hirsh et al., 2004;Shantsila et al., 2009)。常用于不稳定型心绞痛和急性心肌梗死患者,以及血管手术患者(Battistelli et al., 2010)。肝素的施用经常引起血小板计数的减少。这种现象被称为肝素诱导的血小板减少症(HIT),分为I型和II型。为避免两种综合征之间的混淆,“HIT I型”已改为“非免疫性肝素相关性血小板减少症”,“HIT II型”简称为“HIT”。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Heparin-induced thrombocytopenia.
Heparin is an effective anti-coagulant for the prevention of venous thromboembolism and for the treatment of venous thrombosis and pulmonary embolism (Girolami et al., 2003; Hirsh et al., 2004; Shantsila et al., 2009). It is often used for patients with unstable angina and acute myocardial infarction, and for patients who have undergone vascular surgery (Battistelli et al., 2010). The administration of heparin frequently induces a reduction in platelet counts. This phenomenon is called heparin-induced thrombocytopenia (HIT) and be classified as either type I or II. To avoid confusion between the syndromes, “HIT type I” has been changed to “non-immune heparin associated thrombocytopenia”, and ‘‘HIT type II’’ is simply called ‘‘HIT’’.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信